ANTI-S-RBD TITER AND RISK OF CLINICAL PROGRESSION IN PATIENTS WITH COVID-19 PNEUMONIA
Background: Antibodies (Ab) against the receptor-binding-domain of the spike protein (anti-S-RBD) elicited by SARS-CoV-2 infection or vaccination are deemed to be a correlate of protection. We aimed at assessing whether anti-S-RBD titer is associated with the outcome of subjects hospitalized with COVID-related pneumonia. Methods: Adults hospitalized between Jul 2021 and Jul 2022 for COVID-19 with…